|TVM Life Science Venture Capital||Partner||Germany|
Investors’ perspective on investing in MedTech post COVID-19
Dr. Sascha Berger is a Partner at TVM Capital, based in Munich, Germany. TVM Capital is one the pioneer transatlantic Life Science Venture Capital funds with teams based in Europe and North America. Sascha joined TVM Capital in 2016, helped to raise the current $480M fund and works closely with entrepreneurs and founders to advance promising pharmaceutical assets, medtech, diagnostic and digital health technologies to the next value inflection points. Sascha is a passionate VC, a Boston Consulting Group alumnus, and has an academic background in chemistry and finance.